[go: up one dir, main page]

AU5997999A - Grains for oral preparations - Google Patents

Grains for oral preparations

Info

Publication number
AU5997999A
AU5997999A AU59979/99A AU5997999A AU5997999A AU 5997999 A AU5997999 A AU 5997999A AU 59979/99 A AU59979/99 A AU 59979/99A AU 5997999 A AU5997999 A AU 5997999A AU 5997999 A AU5997999 A AU 5997999A
Authority
AU
Australia
Prior art keywords
grains
oral preparations
preparations
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59979/99A
Inventor
Toshio Yajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU5997999A publication Critical patent/AU5997999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
AU59979/99A 1998-09-30 1999-09-29 Grains for oral preparations Abandoned AU5997999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27674998 1998-09-30
JP10/276749 1998-09-30
PCT/JP1999/005316 WO2000018372A1 (en) 1998-09-30 1999-09-29 Grains for oral preparations

Publications (1)

Publication Number Publication Date
AU5997999A true AU5997999A (en) 2000-04-17

Family

ID=17573816

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59979/99A Abandoned AU5997999A (en) 1998-09-30 1999-09-29 Grains for oral preparations

Country Status (2)

Country Link
AU (1) AU5997999A (en)
WO (1) WO2000018372A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6068001A (en) * 2000-06-01 2001-12-11 Taisho Pharmaceutical Co., Ltd. Matrices for oral preparations
US6656492B2 (en) 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
JP3211824B1 (en) * 2000-10-26 2001-09-25 味の素株式会社 Pharmaceutical granule preparation containing branched-chain amino acid and method for producing the same
JP4310605B2 (en) 2001-05-25 2009-08-12 大塚製薬株式会社 Pharmaceutical composition
EP1757277A4 (en) * 2004-06-03 2012-11-21 Taisho Pharmaceutical Co Ltd ORAL PREPARATIONS AND METHOD OF MANUFACTURING THE SAME
JP6572244B2 (en) * 2014-02-25 2019-09-04 オービス バイオサイエンシズ， インク．Ｏｒｂｉｓ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． Taste masking drug formulation
CN104083327B (en) * 2014-07-22 2016-08-24 回音必集团抚州制药有限公司 The purposes of butyl acrylate
FR3027802B1 (en) * 2014-10-31 2018-03-02 Ethypharm DOUBLE MASKING TASTE ACTIVE PRINCIPLE GRANULES, PROCESS FOR THEIR PREPARATION AND ORODISPERSIBLE TABLETS CONTAINING SAME
CN106511317A (en) * 2016-12-13 2017-03-22 浙江中同科技有限公司 Preparing method for taste masking clarithromycin granules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0296516A (en) * 1988-09-29 1990-04-09 Dainippon Pharmaceut Co Ltd Granule and production thereof
JP2915653B2 (en) * 1991-11-14 1999-07-05 第一製薬株式会社 Masked granules
JP3265680B2 (en) * 1992-03-12 2002-03-11 大正製薬株式会社 Oral pharmaceutical composition
ES2194863T3 (en) * 1992-11-30 2003-12-01 Kv Pharm Co PHARMACEUTICAL MATERIALS WITH MASK OF FLAVOR.
JPH07267850A (en) * 1994-03-28 1995-10-17 Eisai Co Ltd Medicine composition prevented in unpleasant taste and method for producing the same

Also Published As

Publication number Publication date
WO2000018372A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
AU9187598A (en) Oral preparation
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU6275399A (en) Perilaryngeal oral airway
AU2003200752A1 (en) Grain cleaner
AU1071200A (en) Systems for oral delivery
AU4143999A (en) Oral composition comprising capsules
AU1304601A (en) Solid preparations for oral use
AU3089199A (en) Preparations containing licariin
AU2610299A (en) Hydrazone derivatives
AU5997999A (en) Grains for oral preparations
AU3404797A (en) Stabilized stannous-containing compositions for oral care
AU9802698A (en) Cubic leucite-containing dental porcelains
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU6480299A (en) Pharmaceutical compounds
AU5378599A (en) Oral formulation
AU1800100A (en) Medicinal preparations
AU4910199A (en) Oral composition
AU2640999A (en) 1-azaindolizine derivatives
AUPP244698A0 (en) Aquaculture system
AU5652199A (en) Sustained release oral preparations
AU5239899A (en) Amidophosphate derivatives
AU2227799A (en) Adapter
AU1041597A (en) Remedy for tragomaschalia containing adrenocorticosteriodal preparation
AU4707599A (en) Denture system
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase